Comparison of Bupivacaine (0.5%) and Bupivacaine (0.5%) with Dexmedetomide for Spinal Anesthesia in Lower Abdominal and Pelvic Surgery

Abstract

Background: Dexmedetomiodine has also been used intrathecally to enhance the duration of motor and
sensory blockade produced by hyperbaric bupivacaine. By increasing the dose of intrathecal dose of intrathecal
dexmedetomidine it has been found that there is a significant increase in duration of motor and sensory blockade
produced by intrathecal hyperbaric bupivacaine. Purpose of this study was to evaluate whether addition of
dexmedetomidine changes the characteristics of bupivacaine 0.5% analgesia and other effects when injected
intrathecally.
Materials & Methods: This prospective, double-blind, randomized, controlled study was conducted in 100
patients of ASA PS I-II, aged between 20-60 yrs, of either sex, scheduled for elective lower abdominal and pelvic
surgery were chosen and divided into two groups. Patients were randomly allocated to receive intrathecally either
3ml of 0.5% hyperbaric bupivacaine plus 1ml normal saline (group X) or 3ml of 0.5% hyperbaric bupivacaine plus
dexmedetomidine 4 µg in 1 ml (group Y). The time taken to achieve peak sensory (T10 dermatome) and motor
blockade (Bromage score 3), duration of block, recovery characteristics and hemodynamic changes were recorded.
Any adverse symptoms like nausea, vomiting, shivering, pruritis, and sedation etc were noted.
Results: The mean time of sensory block to reach T10 dermatome was 5.56±1.23 minutes in Group Y, 6.48±1.18
minutes in Group X.The mean time to reach Bromage 3 scale was 8.94±1.62 minutes in Group Y and 11.88±1.42
minutes in Group X. The regression time to Bromage 0 was 291.7±30.2 minutes for Group Y and 144.8 ±10.5
minutes for Group X. Onset and regression of sensory and motor block were highly significant ( p<0.0001). The
mean time for 2 segment regression was 111.1±14.96 for group Y and 89.2±9.11 for group X (p<0.0001).

Conclusion: The onset of sensory and motor blockade was shortened by dose of dexmedetomidine. The duration
of sensory and motor block was also prolonged. Therefore it can be concluded that dexmedetomidine has effect on
sensory and motor block when used as an adjuvant to bupivacaine in spinal anaesthesia